Taken together, the AMPK-SIRT1/ROS-MAPK/CLOCK-BMAL1 regulatory axis may become a new target for the prevention and treatment of atherosclerosis in the future, pending validation by other investigators. This evidence concerns the gene SIRT1 and atherosclerosis.